Kadenwood
Series B in 2021
Kadenwood is a privately-held consumer products lifestyle company that specializes in cannabidiol (CBD) products aimed at establishing CBD as a trusted and safe option within the mainstream wellness market. The company is committed to quality by utilizing vertically-integrated CBD farming practices, allowing for the production of THC-free CBD oil from seed to shelf. Kadenwood's product offerings include sports creams, roll-ons, oil drops, pet health products, and organic hot teas, all of which comply with farm-bill regulations. Through its focus on quality and innovation, Kadenwood seeks to redefine the CBD industry and promote wellness among its consumers.
Petalfast
Series A in 2021
Petalfast Inc. is a sales and marketing company focused on the cannabis industry, providing a comprehensive suite of services designed to enhance brand visibility and drive growth. Founded in 2020 and based in Middletown, Delaware, Petalfast offers a range of marketing solutions, including brand strategy, graphic identity, packaging design, audience segmentation, retail strategy, and digital content creation. Their sales accelerator comprises six components that can be utilized independently or collectively to maximize impact. By leveraging its marketing expertise, Petalfast assists cannabis brands in developing effective sales strategies, optimizing their market reach, and implementing targeted advertising campaigns. The company's approach is tailored to meet the specific needs of clients in the cannabis sector, enabling them to navigate a competitive landscape and achieve sustainable growth.
Semasio GmbH, founded in 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to provide a platform that helps marketers build detailed user profiles and identify target groups. Semasio's offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, utilizing Natural Language Processing to analyze website content and create comprehensive profiles for both websites and users. This enables clients, including global agency networks and advertisers, to strategically address specific audiences and optimize their advertising efforts. Additionally, Semasio's technology allows for precise control over the contextual placements of online advertising content, ensuring relevance and efficiency. With development centers in Denmark and Portugal, Semasio is dedicated to enhancing the effectiveness of programmatic advertising in a privacy-conscious environment.
Front Range Biosciences
Series B in 2019
Front Range Biosciences, Inc. is an agricultural biotechnology company focused on the breeding and production of innovative plants and seeds in the hemp, coffee, and cannabis sectors. Founded in 2015 and based in Lafayette, Colorado, the company specializes in tissue culture propagation and the development of high-value crops at scale, improving the consistency and efficiency of clone and seed production. Front Range Biosciences features a Clean Stock program which supplies disease- and pest-free plants to farmers while offering data-driven breeding solutions aimed at enhancing commercially relevant traits. The company also provides rooted cuttings, pre-finished plants, and feminized hemp seeds, enabling cultivators to increase yields, reduce disease prevalence, and develop novel strains, ultimately contributing to modern agricultural practices in these industries. Additional offices in Wisconsin, California, and Spain support its operations and research initiatives.
KelSie Biotech
Series A in 2019
KelSie Biotech, LLC is a biotechnology company based in Boulder, Colorado, founded in 2017. It focuses on the research and development of innovative bioavailability delivery methods for sensitive active pharmaceutical ingredients (APIs). The company specializes in creating dry powder inhalable products utilizing their patented bubble drying process and sublingual wafer technology. These advancements enable easier administration of medications, allowing patients to take their daily dosages without difficulty. In addition to product development, KelSie Biotech provides a range of services, including formulation, testing, licensing, trial design, manufacturing, and consulting, to support the pharmaceutical industry in enhancing drug delivery methods.